CompletedNot Applicable

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

Australia380 participantsStarted 2017-01-31

Plain-language summary

This is a multicentre prospective audit to determine the incidence of immunodeficiency in children with IPD. Aims and/or research question of the project 1. To determine the incidence of primary immunodeficiency in children \>2 years who present with IPD 2. To determine the types of immunodeficiency associated with IPD in children

Who can participate

Age range0 Months – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children aged 0 to 18 years admitted to one of the six centres with IPD. Exclusion Criteria: * Children who do not fulfil the age criteria for immunological evaluation at that particular site e.g. aged \<2 years at Royal Children's Hospital. * Children with a known underlying condition predisposing to IPD i.e. nephrotic syndrome.

What they're measuring

incidence of primary immunodeficiency in children who present with invasive pneumococcal disease

Timeframe: 3 years

types of immunodeficiency associated with children who present with invasive pneumococcal disease

Timeframe: 3 years

Trial details

NCT IDNCT03815357

SponsorMurdoch Childrens Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-06-30

View on ClinicalTrials.gov More Invasive Pneumococcal Disease, Recurrent Isolated, 1 trials